CBD 600mg Normalizes Neuroendocrine and Anxiety Responses to Stress in Patients at Risk of Psychosis
How to Cite
OrthoEvidence. CBD 600mg Normalizes Neuroendocrine and Anxiety Responses to Stress in Patients at Risk of Psychosis. ACE Report. 2020;9(8):3. Available from: https://myorthoevidence.com/AceReport/Report/12216
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosisPsychopharmacology. 2020;237:1121-1130
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Thirty-two participants at clinical high risk (CHR) for psychosis were randomized to receive either cannabidiol (CBD) 600 mg/day (CHR-CBD) or placebo (CHR-P) for one week. The CHR participants and 25 healthy controls (HC) then performed a psychosocial stress task. The primary outcome was the neuroendocrine response to stress measured by serum cortisol levels. Other outcomes of interest included su...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE